Regenxbio
RGNX
RGNX
203 hedge funds and large institutions have $2.16B invested in Regenxbio in 2018 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 92 increasing their positions, 49 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.19% more ownership
Funds ownership: 81.49% → 81.68% (+0.19%)
17% less call options, than puts
Call options by funds: $10.3M | Put options by funds: $12.4M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
203
Holding in Top 10
4
Calls
$10.3M
Puts
$12.4M
Top Buyers
| 1 | +$71.5M | |
| 2 | +$38.4M | |
| 3 | +$34.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$27.3M |
| 5 |
Renaissance Technologies
New York
|
+$21.6M |
Top Sellers
| 1 | -$46.8M | |
| 2 | -$39.9M | |
| 3 | -$29.9M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$21.5M |
| 5 |
Citigroup
New York
|
-$7.52M |